Cook Wealth’s TG Therapeutics TGTX Stock Holding History

Cook Wealth’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,810	Closed	-$96K	–	50
2022 Q2	$96K	Hold	12,810	–	–	0.1%	44
2022 Q1	$96K	Buy	+12,810	New	+$148K	0.1%	38

Other funds holding TGTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cook Wealth's TGTX Position: Q3 2022 in Review

Cook Wealth sold out of TG Therapeutics (TGTX) in Q3 2022, closing a stake of 12,810 shares — an estimated $96K sold.

Cook Wealth first reported a position in TGTX in Q1 2022 and held it in 2 quarters. The position peaked at $96K in Q2 2022. 183 funds tracked by Wall St. Rank hold TGTX as of Q3 2022.

Cook Wealth reported no remaining TG Therapeutics position as of Q3 2022 after selling out during the quarter.
Cook Wealth sold 12,810 TG Therapeutics shares in Q3 2022, an estimated $96K.
Cook Wealth first reported a position in TG Therapeutics in Q1 2022 and held it in 2 quarters.
Cook Wealth's TG Therapeutics position peaked at $96K in Q2 2022.
183 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2022.

Based on Cook Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.